Total Payments
$6,475
2024 Payments
$642.58
Companies
38
Transactions
361
Medicare Patients
11,303
Medicare Billing
$647,082
Payment Breakdown by Category
Food & Beverage$6,475 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,475 | 361 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,096 | 67 | $0 (2024) |
| Amgen Inc. | $546.23 | 30 | $0 (2024) |
| PFIZER INC. | $544.80 | 22 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $527.97 | 18 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $471.17 | 29 | $0 (2023) |
| Merck Sharp & Dohme LLC | $467.56 | 32 | $0 (2022) |
| ABBVIE INC. | $441.47 | 26 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $392.17 | 25 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $214.28 | 10 | $0 (2021) |
| Allergan, Inc. | $198.50 | 9 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $642.58 | 32 | PFIZER INC. ($276.60) |
| 2023 | $630.33 | 34 | PFIZER INC. ($230.42) |
| 2022 | $612.53 | 38 | Novo Nordisk Inc ($123.93) |
| 2021 | $1,084 | 66 | AbbVie Inc. ($231.97) |
| 2020 | $539.72 | 38 | Novo Nordisk Inc ($122.37) |
| 2019 | $822.39 | 53 | Amgen Inc. ($171.10) |
| 2018 | $935.42 | 42 | Novo Nordisk Inc ($242.42) |
| 2017 | $1,208 | 58 | AstraZeneca Pharmaceuticals LP ($365.06) |
All Payment Transactions
361 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: Biological | ||||||
| 10/21/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $104.85 | General |
| Category: VACCINES | ||||||
| 10/03/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $23.90 | General |
| Category: NEUROLOGY | ||||||
| 10/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.81 | General |
| Category: Diabetes | ||||||
| 09/30/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $5.74 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/30/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $1.16 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: Diabetes | ||||||
| 09/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Respiratory | ||||||
| 09/09/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $15.89 | General |
| 08/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: Obesity | ||||||
| 08/06/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $11.27 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.51 | General |
| Category: Diabetes | ||||||
| 07/18/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $18.88 | General |
| Category: Insulin Pump | ||||||
| 07/17/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $10.84 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/21/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Diabetes | ||||||
| 05/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Diabetes | ||||||
| 05/17/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Diabetes | ||||||
| 05/13/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $2.48 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/08/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/29/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $10.95 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $11.10 | General |
| Category: Diabetes | ||||||
| 04/18/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY | Food and Beverage | In-kind items and services | $126.20 | General |
| Category: VACCINES | ||||||
| 04/17/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: PSYCHIATRY | ||||||
| 03/19/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 36 | 2,773 | 5,278 | $490,679 | $181,231 |
| 2022 | 37 | 2,714 | 5,395 | $471,947 | $151,847 |
| 2021 | 45 | 3,130 | 5,844 | $506,275 | $174,861 |
| 2020 | 40 | 2,686 | 4,996 | $452,801 | $139,143 |
Total Patients
11,303
Total Services
21,513
Medicare Billing
$647,082
Procedure Codes
158
All Medicare Procedures & Services
158 procedure records from CMS Medicare Utilization — Page 2 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 12 | 12 | $1,020 | $484.92 | 47.5% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 27 | 31 | $2,418 | $428.62 | 17.7% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 46 | 105 | $2,625 | $427.73 | 16.3% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 60 | 112 | $2,464 | $348.32 | 14.1% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 14 | 14 | $1,680 | $234.26 | 13.9% |
| 85610 | Blood test, clotting time | Office | 2023 | 12 | 51 | $765.00 | $201.60 | 26.4% |
| 84550 | Uric acid level, blood | Office | 2023 | 23 | 30 | $420.00 | $128.47 | 30.6% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 13 | 71 | $2,840 | $76.62 | 2.7% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 36 | 190 | $3,800 | $74.70 | 2.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 24 | 81 | $2,025 | $61.85 | 3.1% |
| 85651 | Red blood cell sedimentation rate, to detect inflammation, non-automated | Office | 2023 | 14 | 14 | $252.00 | $58.52 | 23.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 289 | 874 | $209,760 | $71,230 | 34.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 76 | 108 | $30,780 | $13,386 | 43.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 101 | 132 | $19,800 | $8,019 | 40.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 111 | 113 | $7,910 | $7,663 | 96.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 256 | 518 | $36,260 | $5,353 | 14.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 223 | 408 | $30,600 | $5,315 | 17.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 256 | 515 | $12,875 | $3,914 | 30.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 30 | 30 | $4,650 | $3,819 | 82.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 13 | 14 | $5,110 | $3,578 | 70.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 137 | 358 | $18,616 | $3,417 | 18.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 113 | 115 | $3,450 | $3,266 | 94.7% |
| 77067 | Screening mammography | Office | 2022 | 30 | 30 | $9,000 | $2,723 | 30.3% |
| 82306 | Vitamin d-3 level | Office | 2022 | 61 | 87 | $7,134 | $2,540 | 35.6% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 89 | 145 | $7,540 | $2,406 | 31.9% |
About Dr. Ronald Heine, M.D
Dr. Ronald Heine, M.D is a Family Medicine healthcare provider based in Athens, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1013912716.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ronald Heine, M.D has received a total of $6,475 in payments from pharmaceutical and medical device companies, with $642.58 received in 2024. These payments were reported across 361 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($6,475).
As a Medicare-enrolled provider, Heine has provided services to 11,303 Medicare beneficiaries, totaling 21,513 services with total Medicare billing of $647,082. Data is available for 4 years (2020–2023), covering 158 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Athens, TX
- Active Since 06/17/2005
- Last Updated 10/16/2009
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1013912716
Products in Payments
- Ozempic (Drug) $454.33
- FARXIGA (Drug) $286.32
- JANUVIA (Drug) $276.83
- JARDIANCE (Drug) $267.82
- EVENITY (Biological) $265.18
- XARELTO (Drug) $250.59
- LINZESS (Drug) $233.51
- PREVNAR 20 (Biological) $231.05
- ENTRESTO (Drug) $214.28
- PREVNAR 13 (Biological) $179.96
- Wegovy (Drug) $165.28
- REXULTI (Drug) $154.53
- XIFAXAN (Drug) $151.60
- Saxenda (Drug) $149.70
- INVOKANA (Drug) $141.58
- Rybelsus (Drug) $136.32
- Vascepa (Drug) $131.29
- Victoza (Drug) $130.47
- Prolia (Biological) $124.21
- MOUNJARO (Drug) $123.37
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Athens
Farris Johnson, Md, MD
Family Medicine — Payments: $30,847
Family Medicine $30,847
Timothy Law, Do, DO
Family Medicine — Payments: $18,254
Family Medicine $18,254
Dr. Henry Morris, M.d, M.D
Family Medicine — Payments: $16,624
Family Medicine $16,624
Alvin Wilson, D.o, D.O
Family Medicine — Payments: $13,833
Family Medicine $13,833
Dr. James Shiver, M.d, M.D
Family Medicine — Payments: $13,306
Family Medicine $13,306
Dr. Paul Haver, M.d, M.D
Family Medicine — Payments: $11,681
Family Medicine $11,681